BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 12, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Vaccine guidance, adcom a matter of raising public trust

Oct. 7, 2020
By Mari Serebrov
With COVID-19 cases once again surging across the globe and several countries considering targeted lockdowns, vaccines remain the best hope of restoring a sense of normalcy amidst the pandemic. For vaccines to work though, people must have enough confidence in the efficacy and safety that they’re willing to get vaccinated when the vaccines become available. That’s why the emergency use authorization (EUA) guidance the FDA released Oct. 6 for COVID-19 vaccines is so important.
Read More
U.K. flag on stethoscope

Growing concerns over decline in non-COVID-19 clinical testing, says U.K.’s ABPI

Oct. 7, 2020
By Nuala Moran
LONDON – Industry is calling on the government to set out a plan for the safe and sustainable restart of non-COVID-19 clinical studies that were put on hold when the pandemic struck.
Read More

Regulatory actions for Oct. 7, 2020

Oct. 7, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aprea, Arca, Arch, Biomarin, Eton, Lilly, OWP, Pluristem, Polarean, TLC, Y-Mabs.
Read More

Other news to note for Oct. 7, 2020

Oct. 7, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aetion, Anpac, Bintai Kinden, Biogen, Calithera, Citius, Complix, Denali, Foundation, Generex, Greenwich, Innovent, Kindred, Lilly, Mapi, Novellus, Nugenerex, Olix, Provention, Renibus, Spartina, Sunovion, Sunshine, Théa, UCB, Urovant, Vaccibody, Vaxart.
Read More

In the clinic for Oct. 7, 2020

Oct. 7, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abfero, Achieve, BMS, Epizyme, Ilya, Immunitybio, Lilly, Nantkwest, Napo, Onconano, Pfizer, Redhill, Stoke, Teva.
Read More
Illustration of business bar chart being toppled by coronavirus
Virtual Medtech Conference

Pandemic drives lasting changes in med-tech industry

Oct. 6, 2020
By Annette Boyle
COVID-19 has prompted dramatic rethinking of supply chains, health care delivery, regulations, and collaboration that are likely to permanently restructure the med-tech industry, according to industry leaders speaking at a panel during the Advanced Medical Technology Association’s (Advamed) Virtual Medtech Conference on Oct. 6. In addition, the significant increase in debt and strong fundamentals position the industry for a burst of M&A activity.
Read More
Jeff Shuren
Virtual Medtech Conference

FDA’s Shuren pounds on inadequacy of statute in CDRH town hall

Oct. 6, 2020
By Mark McCarty
The annual med-tech conference hosted by the Advanced Medical Technology Association, always features an FDA town hall, but this year’s town hall labored under the overhang of the COVID-19 pandemic. Nonetheless, Jeff Shuren, director of the Center for Devices and Radiological Health (CDRH), repeatedly gave voice to frustration with the statutory authorities currently enjoyed by the center, stating on more than one occasion that the Medical Device Amendments of 1976 are more than 40 years old and are in need of updates to cope with modern medical technology.
Read More
Costa Rican flag

Costa Rica clears the way for untested ventilators developed by its universities

Oct. 6, 2020
By Sergio Held
CAJICA, Colombia –The government of Costa Rica issued guidelines recently that will allow the country’s social security system to source the country's hospitals with ventilators produced by the faculties of the universities of the Latin American country, during the COVID-19 outbreak.
Read More

Other news to note for Oct. 6, 2020

Oct. 6, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, 1Health.io, Abbott Laboratories, Biologica Technologies, Clear, Diagnostic Robotics, Emanate Wireless, Genentech, Imbio, Ion Beam Applications, Iprocedures, Medshape, Mesuron, Mgroup, Neupath Health, Opum US, Pharmajet, Pivot Design Group, Qiagen, Quanterix, Quest Diagnostics, Readcoor, Sanara Medtech, Shin-Ho Instruments, Tyber Medical, Vizient, Xtant Medical.
Read More

In the clinic for Oct. 6, 2020

Oct. 6, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Beckman Coulter, Daxor, Guardant Health.
Read More
Previous 1 2 … 360 361 362 363 364 365 366 367 368 … 553 554 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing